Attached files

file filename
10-K - FORM 10-K - GENOMIC HEALTH INCf58029e10vk.htm
EX-21.1 - EX-21.1 - GENOMIC HEALTH INCf58029exv21w1.htm
EX-12.1 - EX-12.1 - GENOMIC HEALTH INCf58029exv12w1.htm
EX-31.1 - EX-31.1 - GENOMIC HEALTH INCf58029exv31w1.htm
EX-32.1 - EX-32.1 - GENOMIC HEALTH INCf58029exv32w1.htm
EX-31.2 - EX-31.2 - GENOMIC HEALTH INCf58029exv31w2.htm
EX-23.1 - EX-23.1 - GENOMIC HEALTH INCf58029exv23w1.htm
EX-10.14 - EX-10.14 - GENOMIC HEALTH INCf58029exv10w14.htm
EX-10.13 - EX-10.13 - GENOMIC HEALTH INCf58029exv10w13.htm
EX-10.15 - EX-10.15 - GENOMIC HEALTH INCf58029exv10w15.htm
EXHIBIT 32.2
STATEMENT OF CHIEF FINANCIAL OFFICER UNDER 18 U.S.C. § 1350
I, Dean L. Schorno, the chief financial officer of Genomic Health, Inc. (the “Company”), certify for the purposes of section 1350 of chapter 63 of title 18 of the United States Code that, to the best of my knowledge,
     (i) the Annual Report of the Company on Form 10-K for the period ended December 31, 2010 (the “Report”), fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934, and
     (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
         
 
  /s/ Dean L. Schorno
 
Dean L. Schorno
   
 
  Chief Financial Officer    
 
  March 11, 2011